BioSpace News Archive

The research was published in the journal Cancer Discovery.

The new data should give Bayer’s Nubeqa some energy to go after market share held by other drugs approved to treat prostate cancer, including Xtandi.

The focus of the trial, DIAN-TU-001, is looking at drugs that could possibly change the course of the disease.

The spreading of the coronavirus that began in Wuhan, China has researchers and health officials worldwide studying the emerging virus and preparing to treat it and develop vaccines. With such an enormous global focus, it seems that new information about the virus and the infection is being published each day.

Although January was a fairly slow month for PDUFA dates for the U.S. Food and Drug Administration, February has a stronger schedule.

The new AI for Health initiative will focus on three key areas – discovery, global health insights and health equity, a goal to improve access to healthcare across the world.

Three months after Sandoz announced it would acquire the Japanese business of Aspen Global Incorporated, a subsidiary of Aspen Pharmacare Holdings for $330 million, the deal has been completed.

It was another busy week for clinical trial updates. Here’s a look.

The teen who had a double lung transplant after a vaping-related injury is sharing his story in hopes to inspire others – particularly teens – to stop vaping and seek alternatives for a healthier and happier life.

Merz announced that data on the Merz Aesthetics product portfolio, including Belotero®, Cellfina® and Radiesse® will be featured in oral and poster presentations at the 2020 International Master Course on Aging Science World Congress, to be held from 30 January to 1 February 2020 in Paris, France.